Both in Pharmaceuticals
Arvinas vs Evolus
Over the past year ARVN returned −19.1% and EOLS returned +15.0%; their daily moves had a correlation of 0.29.
ARVN −19.1% EOLS +15.0%Growth of $1, one year, split-adjusted
| Metric | ARVN | EOLS |
|---|---|---|
| Price | $7.86 | $7.35 |
| Market cap | $513.9M | $485.5M |
| Today | −0.51% | −2.26% |
| 1 month | +5.8% | −4.4% |
| 6 months | −25.2% | +37.9% |
| Year to date | −33.7% | +10.5% |
| 1 year | −18.0% | +7.1% |
| Revenue growth (YoY) | +1014.7% | +21.2% |
| Gross margin | 96.4% | 68.0% |
| Net margin | 67.8% | −9.6% |
| P/E (TTM) | 55.3× | — |
| Price / sales | 1.6× | 1.5× |
| Net cash | $567.6M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | 46.6% | 52.4% |
| Short % of float | 10.2% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).